The visible nature makes it easy to spot and isolate
En los márgenes del conocimiento médico, un nuevo misterio viral ha emergido entre los niños más pequeños de India: una enfermedad llamada gripe del tomate, que deja ampollas rojas y dolorosas como señales visibles de algo aún no completamente comprendido. Confirmada en al menos 82 casos en Kerala y 26 en Odisha, la enfermedad afecta principalmente a menores de cinco años y desafía el diagnóstico preciso, pues los investigadores aún no han aislado un patógeno específico. Como tantas veces en la historia de la salud pública, la humanidad se enfrenta a lo desconocido armada con herramientas imperfectas: la observación clínica, el aislamiento preventivo y la esperanza de que la visibilidad del mal sea también su límite.
- Una fiebre alta acompañada de ampollas rojas que crecen hasta el tamaño de un tomate ha puesto en alerta a las autoridades sanitarias de varios estados de India desde mayo de 2022.
- El virus no tiene tratamiento específico y su origen exacto sigue sin confirmarse, lo que complica la respuesta médica y genera incertidumbre entre padres y especialistas.
- Expertos sospechan que podría ser una variante de la enfermedad mano-pie-boca, pero el diagnóstico se realiza por descarte, tras excluir dengue, COVID-19 y chikungunya.
- La transmisión ocurre por contacto con superficies contaminadas o con personas sintomáticas, lo que ha llevado a Uttar Pradesh y al gobierno central a emitir guías de prevención para familias.
- Aunque la enfermedad no es mortal y se considera autolimitada, las autoridades advierten que podría volverse grave en adultos inmunocomprometidos si no se contiene a tiempo.
En mayo de 2022, médicos en Kerala comenzaron a notar algo inusual en sus pacientes más jóvenes: fiebre alta acompañada de ampollas rojas y dolorosas que crecían hasta el tamaño de un tomate. La condición, bautizada como gripe del tomate, se extendió rápidamente a otros estados indios. Para finales de agosto, se habían confirmado al menos 82 casos en Kerala y 26 en Odisha, casi todos en niños menores de cinco años.
El virus representa un enigma médico. Investigadores de The Lancet no lograron aislar un patógeno específico, y el diagnóstico se estableció por eliminación, descartando dengue, COVID-19 y chikungunya. El experto en salud pública T. Sundararaman sugirió que podría tratarse de una variante de la enfermedad mano-pie-boca, opinión compartida por el inmunólogo Alfredo Corell, de la Universidad de Valladolid, quien señaló que sin un agente confirmado, los clínicos diagnostican por exclusión.
Los síntomas son inconfundibles: fiebre, dolor articular y ampollas características que crecen con el tiempo. Aunque la enfermedad no es mortal, su apariencia visible facilita la identificación y el aislamiento de los niños afectados, lo que podría favorecer el control del brote si el sistema sanitario actúa con rapidez. La transmisión sigue el patrón de otros virus similares: contacto con superficies contaminadas o con personas sintomáticas.
Sin tratamiento específico disponible, el manejo se basa en cuidados de soporte: paracetamol, reposo y aislamiento. Sundararaman describió la enfermedad como autolimitada y de propagación moderada, factores que podrían facilitar su contención. No obstante, Corell advirtió que en adultos inmunocomprometidos el cuadro podría agravarse. La investigación continúa para determinar si se trata de un virus completamente nuevo o de un patógeno conocido que se manifiesta de forma distinta.
In May of this year, doctors in Kerala, India began seeing something unusual in their youngest patients: a fever accompanied by painful red blisters that swelled to the size of tomatoes. The condition, now called tomato flu, has since spread across Indian states, prompting health authorities to issue alerts and study what appears to be an entirely new viral infection. By late August, at least 82 cases had been confirmed in Kerala alone, with another 26 documented in the eastern state of Odisha. Nearly all the affected children were under five years old.
The virus remains something of a medical puzzle. When researchers at The Lancet examined the outbreak, they could not isolate a specific pathogen—diagnosis came instead by elimination, ruling out dengue, COVID-19, and chikungunya before settling on tomato flu as the working name. T. Sundararaman, a public health expert and former director of India's National Health Systems Resource Centre, suggested to international news agencies that the illness may be a variant of hand-foot-mouth disease, a condition already familiar to pediatricians in southern India. Alfredo Corell, an immunologist at the University of Valladolid, echoed this assessment, noting that without a confirmed virus, clinicians were diagnosing by process of elimination rather than by identifying a specific agent.
The symptoms themselves are unmistakable once they appear. Patients develop high fever, joint pain, and a rash that progresses into those characteristic blisters—red, painful, and growing larger over time. The condition is not fatal, researchers confirmed, but the visible nature of the infection makes it easy to spot and isolate affected children. This visibility, Sundararaman suggested, could actually work in public health's favor: if the healthcare system responds quickly, the spread might be contained before it becomes an epidemic.
Transmission appears to follow the pattern of other hand-foot-mouth viruses. The infection spreads through contact with contaminated surfaces and through direct contact with symptomatic individuals. In response, the northern state of Uttar Pradesh issued guidance to parents, instructing them to teach their children to avoid embracing or touching other children showing signs of fever or rash. The Indian government itself issued similar alerts during the same week. Corell noted that while the virus poses little concern for healthy children, it could become serious in adults and particularly in immunocompromised individuals.
What makes tomato flu especially challenging is the absence of any specific treatment. Health authorities have made clear that no targeted therapy exists—much like dengue or chikungunya. Instead, management relies on supportive care: paracetamol for fever and pain, rest, and isolation to prevent spread. Sundararaman characterized the illness as self-limiting and noted that it does not spread with particular speed, a factor that could help contain it if public health systems mobilize effectively. The outbreak remains under study, with researchers working to understand whether this is truly a novel virus or a known pathogen presenting in a new way.
Citas Notables
The disease is self-limiting and does not spread very rapidly, though if the public health sector activates, we will not have an epidemic— T. Sundararaman, public health expert and former director of India's National Health Systems Resource Centre
It is not concerning in children, but in adults and especially in immunocompromised individuals, this type of infection can be serious— Alfredo Corell, immunologist at the University of Valladolid
La Conversación del Hearth Otra perspectiva de la historia
Why does it get called tomato flu if it's not actually influenza?
The name comes from what you see on the skin—blisters that swell to the size of tomatoes. It's descriptive rather than scientific. The actual virus hasn't been identified yet, so the name stuck because it's what people notice first.
If they can't identify the virus, how do doctors know what they're treating?
They work backward. They test for dengue, COVID, chikungunya, and other known viruses. When all those come back negative, and the symptoms match this pattern, they call it tomato flu. It's diagnosis by elimination.
Is this something that could spread beyond India?
Possibly. But experts think it may be a variant of hand-foot-mouth disease, which is already common in southern India. The fact that it spreads through contact with surfaces and sick people means it could travel, but the visible blisters make isolation easier than with invisible viruses.
What worries you most about this outbreak?
That it's still being studied. We don't know if 82 cases is the beginning of something larger or if it's already plateauing. The lack of a specific treatment means we're only managing symptoms. If it reaches immunocompromised people, that's when it could become serious.
Can parents do anything to protect their children right now?
Keep them away from other sick children, avoid touching contaminated surfaces, and watch for fever or rash. The good news is you can see it coming—there's no hidden spread. If a child shows symptoms, isolate them quickly.